DPOC-4088

DRUG2 trials

Sponsors

Diakron Pharmaceuticals

Conditions

Deep Vein Thrombosis LegStroke (in Patients With Atrial Fibrillation)

Phase 1

A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting

CompletedNCT01347203

Diakron PharmaceuticalsDeep Vein Thrombosis Leg

Start: 2011-04-30End: 2011-06-30Target: 12Updated: 2011-07-07

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

TerminatedNCT01647620

Diakron PharmaceuticalsDeep Vein Thrombosis Leg, Stroke (in Patients With Atrial Fibrillation)

Start: 2012-02-29End: 2012-09-30Target: 30Updated: 2015-02-24